Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer

PURPOSE: This phase II study examined whether the addition of simvastatin to afatinib provides a clinical benefit compared with afatinib monotherapy in previously treated patients with nonadenocarcinomatous non-small cell lung cancer (NA-NSCLC). MATERIALS AND METHODS: Patients with advanced NA-NSCLC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Lee, Youngjoo, Lee, Ki Hyeong, Lee, Geon Kook, Lee, Soo-Hyun, Lim, Kun Young, Joo, Jungnam, Go, Yun Jung, Lee, Jin Soo, Han, Ji-Youn
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5654166/
https://ncbi.nlm.nih.gov/pubmed/28111428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados